Refractory anemia with excess of blasts in transformation. Clinical, hematologic, and cytogenetic findings in nine patients.
Smadja N, Krulik M, de Gramont A, Gonzalez-Canali G, Audebert AA, Debray J.
Cancer Genet Cytogenet. 1989 Oct 1;42(1):55-65. doi: 10.1016/0165-4608(89)90008-3.
Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.
Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5.
Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.
Salim O, Toptas T, Avsar E, Yucel OK, Ozturk E, Ferhanoglu B, Geduk A, Mehtap O, Tombak A, Tiftik EN, Deveci B, Kurtoglu E, Kara O, Atagunduz IK, Tuglular TF, Undar L.
Leuk Res. 2016 Jun;45:82-9. doi: 10.1016/j.leukres.2016.04.003. Epub 2016 Apr 11.
Biological characterization of refractory anemia with excess of blasts.
Maiolo AT, Foa P, Pagetti D, Baldini L, Mozzana R, Ortolani S, Colantoni A, Lombardi L, Lavezzi AM, Polli EE.
Haematologica. 1987 Nov-Dec;72(6 Suppl):126-9.
Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.
Kikuchi A, Hasegawa D, Ohtsuka Y, Hamamoto K, Kojima S, Okamura J, Nakahata T, Manabe A; Japanese Paediatric Myelodysplastic Syndrome (MDS) Study Group.
Br J Haematol. 2012 Sep;158(5):657-61. doi: 10.1111/j.1365-2141.2012.09210.x. Epub 2012 Jun 26.
Refractory anemia with excess of blasts: increased survival when treated with cyclophosphamide, methotrexate and 6-mercaptopurine.
Majluf-Cruz A, Hurtado R, Vargas-Vorackova F, Labardini-Méndez J.
Eur J Haematol. 1999 Apr;62(4):213-8. doi: 10.1111/j.1600-0609.1999.tb01749.x.
[Myelodysplastic syndrome classification].
Ghariani I, Braham N, Hassine M, Kortas M.
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804.
Characterization of clonogenic cells in refractory anemia with excess of blasts (RAEB-CFU): response to recombinant hematopoietic growth factors and maturation phenotypes.
Schouten HC, Delwel R, Bot FJ, Hagemeijer A, Touw IP, Löwenberg B.
Leuk Res. 1989;13(3):245-51. doi: 10.1016/0145-2126(89)90019-2.
Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J, Zhou XF, Zhao F, Zhou JF, Chen Y.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Feb;17(1):111-6.
Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2).
Grantham JT, Howell DM, Bacaj PJ, Coad JE, Vos JA.
W V Med J. 2015 Nov-Dec;111(6):34-6.
